sophocarpine has been researched along with Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Y; Xu, JS; Zhou, W | 1 |
| Chu, H; Ge, Z; Li, J; Li, L; Sun, X | 1 |
2 other study(ies) available for sophocarpine and Fibrosis
| Article | Year |
|---|---|
Sophocarpine Alleviates Isoproterenol-Induced Kidney Injury by Suppressing Inflammation, Apoptosis, Oxidative Stress and Fibrosis.
Topics: Alkaloids; Animals; Apoptosis; Fibrosis; Inflammation; Isoproterenol; Kidney; Mice; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Toll-Like Receptor 4; Transforming Growth Factor beta1 | 2022 |
Oral sophocarpine protects rat heart against pressure overload-induced cardiac fibrosis.
Topics: Administration, Oral; Alkaloids; Animals; Cardiotonic Agents; Fibrosis; Male; Myocardium; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction, Left | 2014 |